Dementia Big
The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease.
The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease.
from Dementia Big http://ift.tt/1Tlbfvn via alcoholic dementia
The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease.
from Dementia Big http://ift.tt/1Tlbfvn
via Stopping Dementia
Dementia Big
The impact of blood pressure on brain volumes may be time-dependent or pattern-dependent.
The impact of blood pressure on brain volumes may be time-dependent or pattern-dependent.
from Dementia Big http://ift.tt/1roBn27
via Stopping Dementia
The impact of blood pressure on brain volumes may be time-dependent or pattern-dependent.
from Dementia Big http://ift.tt/1roBn27 via alcoholic dementia
Dementia Big
Neurofibrillary pathology of abnormally hyperphosphorylated tau (P-tau) is a hallmark of Alzheimer’s disease (AD) and other tauopathies. Tau pathology can be experimentally induced and propagated. However, what induces the prion-like transmission character to tau and produces morphologically distinct tau lesions remains elusive.
Neurofibrillary pathology of abnormally hyperphosphorylated tau (P-tau) is a hallmark of Alzheimer’s disease (AD) and other tauopathies. Tau pathology can be experimentally induced and propagated. However, what induces the prion-like transmission character to tau and produces morphologically distinct tau lesions remains elusive.
from Dementia Big http://ift.tt/23byVHW
via Stopping Dementia
Neurofibrillary pathology of abnormally hyperphosphorylated tau (P-tau) is a hallmark of Alzheimer’s disease (AD) and other tauopathies. Tau pathology can be experimentally induced and propagated. However, what induces the prion-like transmission character to tau and produces morphologically distinct tau lesions remains elusive.
from Dementia Big http://ift.tt/23byVHW via alcoholic dementia
Dementia Big
A new study has uncovered an increased risk of dementia–in particular Alzheimer’s disease–in patients with rosacea. Importantly, the risk was highest in older patients and in patients where rosacea was diagnosed by a hospital dermatologist. The findings are published in the Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society.
Dementia Big
Researchers in Denmark have released findings from a small clinical trial of the diabetes drug liraglutide in people living with Alzheimer’s disease.
Dementia Big
A new study has uncovered an increased risk of dementia—in particular Alzheimer’s disease—in patients with rosacea. Importantly, the risk was highest in older patients and in patients where rosacea was diagnosed by a hospital dermatologist. The findings are published in the Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society.
A new study has uncovered an increased risk of dementia—in particular Alzheimer’s disease—in patients with rosacea. Importantly, the risk was highest in older patients and in patients where rosacea was diagnosed by a hospital dermatologist. The findings are published in the Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society.
from Dementia Big http://ift.tt/1VTLCZo
via Stopping Dementia
Researchers in Denmark have released findings from a small clinical trial of the diabetes drug liraglutide in people living with Alzheimer’s disease.
from Dementia Big http://ift.tt/24mgaEc
via Stopping Dementia
A new study has uncovered an increased risk of dementia–in particular Alzheimer’s disease–in patients with rosacea. Importantly, the risk was highest in older patients and in patients where rosacea was diagnosed by a hospital dermatologist. The findings are published in the Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society.
from Dementia Big http://ift.tt/1qYvNCZ
via Stopping Dementia
A new study has uncovered an increased risk of dementia–in particular Alzheimer’s disease–in patients with rosacea. Importantly, the risk was highest in older patients and in patients where rosacea was diagnosed by a hospital dermatologist. The findings are published in the Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society.
from Dementia Big http://ift.tt/1qYvNCZ via alcoholic dementia
Researchers in Denmark have released findings from a small clinical trial of the diabetes drug liraglutide in people living with Alzheimer’s disease.
from Dementia Big http://ift.tt/24mgaEc via alcoholic dementia
A new study has uncovered an increased risk of dementia—in particular Alzheimer’s disease—in patients with rosacea. Importantly, the risk was highest in older patients and in patients where rosacea was diagnosed by a hospital dermatologist. The findings are published in the Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society.
from Dementia Big http://ift.tt/1VTLCZo via alcoholic dementia
Amyloid-beta (Aβ) peptide oligomerization plays a central role in the pathogenesis of Alzheimer’s disease (AD), and Aβ oligomers are collectively considered an appealing therapeutic target for the treatment of AD. However, the molecular mechanisms leading to the pathologic accumulation of oligomers are unclear, and the exact structural composition of oligomers is being debated. Using targeted and quantitative mass spectrometry, we reveal site-specific Aβ autocleavage during the early phase of aggregation, producing a typical Aβ fragment signature and that truncated Aβ peptides can form stable oligomeric complexes with full-length Aβ peptide.
from Dementia Big http://ift.tt/1SztAFf
via Stopping Dementia
Dementia Big
Amyloid-beta (Aβ) peptide oligomerization plays a central role in the pathogenesis of Alzheimer’s disease (AD), and Aβ oligomers are collectively considered an appealing therapeutic target for the treatment of AD. However, the molecular mechanisms leading to the pathologic accumulation of oligomers are unclear, and the exact structural composition of oligomers is being debated. Using targeted and quantitative mass spectrometry, we reveal site-specific Aβ autocleavage during the early phase of aggregation, producing a typical Aβ fragment signature and that truncated Aβ peptides can form stable oligomeric complexes with full-length Aβ peptide.
Amyloid-beta (Aβ) peptide oligomerization plays a central role in the pathogenesis of Alzheimer’s disease (AD), and Aβ oligomers are collectively considered an appealing therapeutic target for the treatment of AD. However, the molecular mechanisms leading to the pathologic accumulation of oligomers are unclear, and the exact structural composition of oligomers is being debated. Using targeted and quantitative mass spectrometry, we reveal site-specific Aβ autocleavage during the early phase of aggregation, producing a typical Aβ fragment signature and that truncated Aβ peptides can form stable oligomeric complexes with full-length Aβ peptide.
from Dementia Big http://ift.tt/1SztAFf via alcoholic dementia
Researchers testing the potential positive effects of “micro-injury” by brief insertion of a small needle into the hippocampal region of mice modeled with Alzheimer’s disease (AD) have found that the procedure not only stimulated the hippocampus into regenerative activity, but also reduced β-amyloid plaques, a hallmark of AD.
from Dementia Big http://ift.tt/1MW3yPB via alcoholic dementia
Today, researchers at the Fisher Center for Alzheimer’s Research Foundation report the results of two new studies conducted by the Fisher Center scientists at Rockefeller University, led by Nobel Laureate Dr. Paul Greengard, in the quest to find a cure for Alzheimer’s disease.
from Dementia Big http://ift.tt/1Spjpqd via alcoholic dementia
A study conducted by researchers at Columbia University Medical Center found that older adults who used a hearing aid performed significantly better on cognitive tests than those who did not use a hearing aid, despite having poorer hearing. The study was published online in the American Journal of Geriatric Psychiatry.
from Dementia Big http://ift.tt/1NOX3Jp via alcoholic dementia
Dementia Big
Researchers testing the potential positive effects of “micro-injury” by brief insertion of a small needle into the hippocampal region of mice modeled with Alzheimer’s disease (AD) have found that the procedure not only stimulated the hippocampus into regenerative activity, but also reduced β-amyloid plaques, a hallmark of AD.
Dementia Big
Today, researchers at the Fisher Center for Alzheimer’s Research Foundation report the results of two new studies conducted by the Fisher Center scientists at Rockefeller University, led by Nobel Laureate Dr. Paul Greengard, in the quest to find a cure for Alzheimer’s disease.
Dementia Big
A study conducted by researchers at Columbia University Medical Center found that older adults who used a hearing aid performed significantly better on cognitive tests than those who did not use a hearing aid, despite having poorer hearing. The study was published online in the American Journal of Geriatric Psychiatry.
A study conducted by researchers at Columbia University Medical Center found that older adults who used a hearing aid performed significantly better on cognitive tests than those who did not use a hearing aid, despite having poorer hearing. The study was published online in the American Journal of Geriatric Psychiatry.
from Dementia Big http://ift.tt/1NOX3Jp
via Stopping Dementia
Researchers testing the potential positive effects of “micro-injury” by brief insertion of a small needle into the hippocampal region of mice modeled with Alzheimer’s disease (AD) have found that the procedure not only stimulated the hippocampus into regenerative activity, but also reduced β-amyloid plaques, a hallmark of AD.
from Dementia Big http://ift.tt/1MW3yPB
via Stopping Dementia
Today, researchers at the Fisher Center for Alzheimer’s Research Foundation report the results of two new studies conducted by the Fisher Center scientists at Rockefeller University, led by Nobel Laureate Dr. Paul Greengard, in the quest to find a cure for Alzheimer’s disease.
from Dementia Big http://ift.tt/1Spjpqd
via Stopping Dementia
(HealthDay)—Plasma homocysteine (HC) and its metabolite homocysteine thiolactone (HCTL) contribute to Alzheimer’s disease (AD) pathology via the amyloid-β (Aβ)-fibrinogen interaction, according to a study published online April 19 in the Journal of Thrombosis and Haemostasis.
from Dementia Big http://ift.tt/1NtKKHs
via Stopping Dementia
Earlier this year, we introduced you to WeCureALZ – a groundbreaking new project that for the first time is set to use the power of citizen science to conduct Alzheimer’s research. Enabled by the support of the BrightFocus Foundation, the team is already preparing for the alpha testing of our first online activity – a game that will allow everyone to search for stalled capillaries in the brains of Alzheimer’s-affected mice.
from Dementia Big http://ift.tt/1NL6l99
via Stopping Dementia
A review of studies of possible linkages between type 2 diabetes and hearing impairment concludes there is compelling evidence that diabetes can damage the auditory system, and that clinicians should include hearing testing in managing type 2 diabetes. The survey results were published in an article titled, “Type 2 Diabetes and Hearing Impairment” in the journal, Current Diabetes Reports.
from Dementia Big http://ift.tt/21c8QZP
via Stopping Dementia
Accumulation of hyperphosphorylated tau and the disruption of microtubules are correlated with synaptic loss and pathology of Alzheimer’s disease (AD). Impaired cognitive function and pathology of AD is correlated with this lesion. This review looks at the mechanism of neurodegeneration, the prion-like behavior of tau in its interaction with normal MAPs in correlation with tau hyperphosphorylation.
from Dementia Big http://ift.tt/1QxOIJX
via Stopping Dementia
O-GlcNAcylation is the posttranslational modification of intracellular proteins by O-linked β-N-acetylglucosamine (O-GlcNAc). The discovery of O-GlcNAc modification of tau and its impact on tau phosphorylation has attracted recent research interest in O-GlcNAc studies in the Alzheimer’s disease (AD) field. Modification of proteins by O-GlcNAc occurs extensively in the brain. The expressions and activities of the enzymes catalyzing O-GlcNAc cycling are several-fold higher in the brain than in the peripheral tissues.
from Dementia Big http://ift.tt/1rvJfiJ
via Stopping Dementia
Dementia Big
A review of studies of possible linkages between type 2 diabetes and hearing impairment concludes there is compelling evidence that diabetes can damage the auditory system, and that clinicians should include hearing testing in managing type 2 diabetes. The survey results were published in an article titled, “Type 2 Diabetes and Hearing Impairment” in the journal, Current Diabetes Reports.
Dementia Big
(HealthDay)—Plasma homocysteine (HC) and its metabolite homocysteine thiolactone (HCTL) contribute to Alzheimer’s disease (AD) pathology via the amyloid-β (Aβ)-fibrinogen interaction, according to a study published online April 19 in the Journal of Thrombosis and Haemostasis.
Dementia Big
O-GlcNAcylation is the posttranslational modification of intracellular proteins by O-linked β-N-acetylglucosamine (O-GlcNAc). The discovery of O-GlcNAc modification of tau and its impact on tau phosphorylation has attracted recent research interest in O-GlcNAc studies in the Alzheimer’s disease (AD) field. Modification of proteins by O-GlcNAc occurs extensively in the brain. The expressions and activities of the enzymes catalyzing O-GlcNAc cycling are several-fold higher in the brain than in the peripheral tissues.
Dementia Big
Earlier this year, we introduced you to WeCureALZ – a groundbreaking new project that for the first time is set to use the power of citizen science to conduct Alzheimer’s research. Enabled by the support of the BrightFocus Foundation, the team is already preparing for the alpha testing of our first online activity – a game that will allow everyone to search for stalled capillaries in the brains of Alzheimer’s-affected mice.
Dementia Big
Accumulation of hyperphosphorylated tau and the disruption of microtubules are correlated with synaptic loss and pathology of Alzheimer’s disease (AD). Impaired cognitive function and pathology of AD is correlated with this lesion. This review looks at the mechanism of neurodegeneration, the prion-like behavior of tau in its interaction with normal MAPs in correlation with tau hyperphosphorylation.
A review of studies of possible linkages between type 2 diabetes and hearing impairment concludes there is compelling evidence that diabetes can damage the auditory system, and that clinicians should include hearing testing in managing type 2 diabetes. The survey results were published in an article titled, “Type 2 Diabetes and Hearing Impairment” in the journal, Current Diabetes Reports.
from Dementia Big http://ift.tt/21c8QZP via alcoholic dementia
(HealthDay)—Plasma homocysteine (HC) and its metabolite homocysteine thiolactone (HCTL) contribute to Alzheimer’s disease (AD) pathology via the amyloid-β (Aβ)-fibrinogen interaction, according to a study published online April 19 in the Journal of Thrombosis and Haemostasis.
from Dementia Big http://ift.tt/1NtKKHs via alcoholic dementia
O-GlcNAcylation is the posttranslational modification of intracellular proteins by O-linked β-N-acetylglucosamine (O-GlcNAc). The discovery of O-GlcNAc modification of tau and its impact on tau phosphorylation has attracted recent research interest in O-GlcNAc studies in the Alzheimer’s disease (AD) field. Modification of proteins by O-GlcNAc occurs extensively in the brain. The expressions and activities of the enzymes catalyzing O-GlcNAc cycling are several-fold higher in the brain than in the peripheral tissues.
from Dementia Big http://ift.tt/1rvJfiJ via alcoholic dementia
Accumulation of hyperphosphorylated tau and the disruption of microtubules are correlated with synaptic loss and pathology of Alzheimer’s disease (AD). Impaired cognitive function and pathology of AD is correlated with this lesion. This review looks at the mechanism of neurodegeneration, the prion-like behavior of tau in its interaction with normal MAPs in correlation with tau hyperphosphorylation.
from Dementia Big http://ift.tt/1QxOIJX via alcoholic dementia
Earlier this year, we introduced you to WeCureALZ – a groundbreaking new project that for the first time is set to use the power of citizen science to conduct Alzheimer’s research. Enabled by the support of the BrightFocus Foundation, the team is already preparing for the alpha testing of our first online activity – a game that will allow everyone to search for stalled capillaries in the brains of Alzheimer’s-affected mice.
from Dementia Big http://ift.tt/1NL6l99 via alcoholic dementia
Dementia Big
Research conducted in the UK has found a 20% drop in the incidence of dementia over the past 2 decades, leading to an estimated 41,000 fewer cases per year in people aged 65 years and older than previously expected.
Dementia Big
In a newly published, pilot study in the journal Ethnicity & Disease, researchers report a relatively low prevalence of vascular risk among participants of the Southwest Heart Mind Study, especially among those treated for hypertension and hyperlipidemia despite overweight and obesity.
Dementia Big
University of Florida Health researchers have developed a unique mouse model that will allow researchers around the world to better study the genetic origins and potential treatments for a neurodegenerative brain disease that causes amyotrophic lateral sclerosis, often referred to as ALS or Lou Gehrig’s disease, and frontotemporal dementia.
University of Florida Health researchers have developed a unique mouse model that will allow researchers around the world to better study the genetic origins and potential treatments for a neurodegenerative brain disease that causes amyotrophic lateral sclerosis, often referred to as ALS or Lou Gehrig’s disease, and frontotemporal dementia.
from Dementia Big http://ift.tt/1WKLN8a via alcoholic dementia
Research conducted in the UK has found a 20% drop in the incidence of dementia over the past 2 decades, leading to an estimated 41,000 fewer cases per year in people aged 65 years and older than previously expected.
from Dementia Big http://ift.tt/1SzIq0H via alcoholic dementia
In a newly published, pilot study in the journal Ethnicity & Disease, researchers report a relatively low prevalence of vascular risk among participants of the Southwest Heart Mind Study, especially among those treated for hypertension and hyperlipidemia despite overweight and obesity.
from Dementia Big http://ift.tt/1MNni7Y via alcoholic dementia
In a newly published, pilot study in the journal Ethnicity & Disease, researchers report a relatively low prevalence of vascular risk among participants of the Southwest Heart Mind Study, especially among those treated for hypertension and hyperlipidemia despite overweight and obesity.
from Dementia Big http://ift.tt/1MNni7Y
via Stopping Dementia
Research conducted in the UK has found a 20% drop in the incidence of dementia over the past 2 decades, leading to an estimated 41,000 fewer cases per year in people aged 65 years and older than previously expected.
from Dementia Big http://ift.tt/1SzIq0H
via Stopping Dementia
University of Florida Health researchers have developed a unique mouse model that will allow researchers around the world to better study the genetic origins and potential treatments for a neurodegenerative brain disease that causes amyotrophic lateral sclerosis, often referred to as ALS or Lou Gehrig’s disease, and frontotemporal dementia.
from Dementia Big http://ift.tt/1WKLN8a
via Stopping Dementia
Dementia Big
Florida Atlantic University’s Charles E. Schmidt College of Medicine is spearheading the South Florida site for the first U.S. clinical trial for Lewy body dementia (LBD), the second-most common dementia after Alzheimer’s disease. The HEADWAY-DLB is a phase 2b multi-center, double-blind, placebo-controlled study to evaluate an investigational medicine, RVT-101, for dementia with Lewy bodies.
Dementia Big
Long before Alzheimer’s disease can be diagnosed clinically, increasing difficulties building cognitive maps of new surroundings may herald the eventual clinical onset of the disorder, finds new research from Washington University in St. Louis.
Dementia Big
Frontotemporal dementia (FTD), the second most common cause of dementia in people under 65, may be triggered by a defect in immune cells called microglia that causes them to consume the brain’s synaptic connections, according to new research led by UCSF scientists.
Dementia Big
Mild-AD subjects without significant Aβ pathology represent a confounding finding for clinical trials because they may not progress clinically on the expected trajectory, adding variance into analyses where slowing of progression is being measured.
Dementia Big
For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer’s disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.
Florida Atlantic University’s Charles E. Schmidt College of Medicine is spearheading the South Florida site for the first U.S. clinical trial for Lewy body dementia (LBD), the second-most common dementia after Alzheimer’s disease. The HEADWAY-DLB is a phase 2b multi-center, double-blind, placebo-controlled study to evaluate an investigational medicine, RVT-101, for dementia with Lewy bodies.
from Dementia Big http://ift.tt/1Sgs3qW
via Stopping Dementia
Frontotemporal dementia (FTD), the second most common cause of dementia in people under 65, may be triggered by a defect in immune cells called microglia that causes them to consume the brain’s synaptic connections, according to new research led by UCSF scientists.
from Dementia Big http://ift.tt/1por7oW
via Stopping Dementia
For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer’s disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.
from Dementia Big http://ift.tt/1Qq8arW
via Stopping Dementia
Long before Alzheimer’s disease can be diagnosed clinically, increasing difficulties building cognitive maps of new surroundings may herald the eventual clinical onset of the disorder, finds new research from Washington University in St. Louis.
from Dementia Big http://ift.tt/1NDWwK2
via Stopping Dementia
Mild-AD subjects without significant Aβ pathology represent a confounding finding for clinical trials because they may not progress clinically on the expected trajectory, adding variance into analyses where slowing of progression is being measured.
from Dementia Big http://ift.tt/1XLUrS9
via Stopping Dementia
Florida Atlantic University’s Charles E. Schmidt College of Medicine is spearheading the South Florida site for the first U.S. clinical trial for Lewy body dementia (LBD), the second-most common dementia after Alzheimer’s disease. The HEADWAY-DLB is a phase 2b multi-center, double-blind, placebo-controlled study to evaluate an investigational medicine, RVT-101, for dementia with Lewy bodies.
from Dementia Big http://ift.tt/1Sgs3qW via alcoholic dementia
Long before Alzheimer’s disease can be diagnosed clinically, increasing difficulties building cognitive maps of new surroundings may herald the eventual clinical onset of the disorder, finds new research from Washington University in St. Louis.
from Dementia Big http://ift.tt/1NDWwK2 via alcoholic dementia
Frontotemporal dementia (FTD), the second most common cause of dementia in people under 65, may be triggered by a defect in immune cells called microglia that causes them to consume the brain’s synaptic connections, according to new research led by UCSF scientists.
from Dementia Big http://ift.tt/1por7oW via alcoholic dementia
Mild-AD subjects without significant Aβ pathology represent a confounding finding for clinical trials because they may not progress clinically on the expected trajectory, adding variance into analyses where slowing of progression is being measured.
from Dementia Big http://ift.tt/1XLUrS9 via alcoholic dementia
For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer’s disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.
from Dementia Big http://ift.tt/1Qq8arW via alcoholic dementia
A tiered diagnostic approach that incorporates clinical, imaging and laboratory data may help physicians more efficiently screen for neurodegenerative disorders such as dementia, according to the consensus of a multi-disciplinary panel of experts.
from Dementia Big http://ift.tt/1YIIoVV via alcoholic dementia
Florida Atlantic University’s Charles E. Schmidt College of Medicine is spearheading the South Florida site for the first U.S. clinical trial for Lewy body dementia (LBD), the second-most common dementia after Alzheimer’s disease. The HEADWAY-DLB is a phase 2b multi-center, double-blind, placebo-controlled study to evaluate an investigational medicine, RVT-101, for dementia with Lewy bodies.
from Dementia Big http://ift.tt/23LuaKH via alcoholic dementia
In Alzheimer’s disease (AD), pathologic amyloid-beta (Aβ) is synaptotoxic and impairs neuronal function at the microscale, influencing brain networks at the macroscale before Aβ deposition. The latter can be detected noninvasively, in vivo, using resting-state functional MRI (rsfMRI), a technique used to assess brain functional connectivity (FC).
from Dementia Big http://ift.tt/1WH7oOT via alcoholic dementia
Dementia Big
Florida Atlantic University’s Charles E. Schmidt College of Medicine is spearheading the South Florida site for the first U.S. clinical trial for Lewy body dementia (LBD), the second-most common dementia after Alzheimer’s disease. The HEADWAY-DLB is a phase 2b multi-center, double-blind, placebo-controlled study to evaluate an investigational medicine, RVT-101, for dementia with Lewy bodies.
Dementia Big
A tiered diagnostic approach that incorporates clinical, imaging and laboratory data may help physicians more efficiently screen for neurodegenerative disorders such as dementia, according to the consensus of a multi-disciplinary panel of experts.
Dementia Big
In Alzheimer’s disease (AD), pathologic amyloid-beta (Aβ) is synaptotoxic and impairs neuronal function at the microscale, influencing brain networks at the macroscale before Aβ deposition. The latter can be detected noninvasively, in vivo, using resting-state functional MRI (rsfMRI), a technique used to assess brain functional connectivity (FC).
A tiered diagnostic approach that incorporates clinical, imaging and laboratory data may help physicians more efficiently screen for neurodegenerative disorders such as dementia, according to the consensus of a multi-disciplinary panel of experts.
from Dementia Big http://ift.tt/1YIIoVV
via Stopping Dementia
Florida Atlantic University’s Charles E. Schmidt College of Medicine is spearheading the South Florida site for the first U.S. clinical trial for Lewy body dementia (LBD), the second-most common dementia after Alzheimer’s disease. The HEADWAY-DLB is a phase 2b multi-center, double-blind, placebo-controlled study to evaluate an investigational medicine, RVT-101, for dementia with Lewy bodies.
from Dementia Big http://ift.tt/23LuaKH
via Stopping Dementia
In Alzheimer’s disease (AD), pathologic amyloid-beta (Aβ) is synaptotoxic and impairs neuronal function at the microscale, influencing brain networks at the macroscale before Aβ deposition. The latter can be detected noninvasively, in vivo, using resting-state functional MRI (rsfMRI), a technique used to assess brain functional connectivity (FC).
from Dementia Big http://ift.tt/1WH7oOT
via Stopping Dementia
Dementia Big
For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer’s disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.
Dementia Big
A new study from the Indiana University Center for Aging Research and the Regenstrief Institute has found that almost half of all long-stay nursing home residents experience at least one transfer to an Emergency Department over the course of a year regardless of their cognitive status. While a high percentage of long-stay nursing home residents were sent to the ED, only about a third of these individuals were subsequently admitted to the hospital.
Dementia Big
The effects of the plaques on the brains of Alzheimer’s patients are devastating.
Dementia Big
Traumatic brain injury (TBI), a leading cause of death and disability, has become so common in recent times that it has been called a “silent epidemic.” And because older adults are more likely to suffer TBI, have worse outcomes, and are less likely to survive their injury than younger adults, older adults are considered a “silent population” within this epidemic.
Dementia Big
Long before Alzheimer’s disease can be diagnosed clinically, increasing difficulties building cognitive maps of new surroundings may herald the eventual clinical onset of the disorder, finds new research from Washington University in St. Louis.
Dementia Big
In a study published in the Journal of the American Geriatrics Society, researchers examined whether or not antipsychotic drugs, which are sometimes used to prevent or treat delirium, are effective.
Dementia Big
We studied the mortality risk of long term and new antipsychotic drug use in Alzheimer’s disease (AD) patients in Japan to determine improved treatment protocols.
For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer’s disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.
from Dementia Big http://ift.tt/1SkPOuy
via Stopping Dementia
A new study from the Indiana University Center for Aging Research and the Regenstrief Institute has found that almost half of all long-stay nursing home residents experience at least one transfer to an Emergency Department over the course of a year regardless of their cognitive status. While a high percentage of long-stay nursing home residents were sent to the ED, only about a third of these individuals were subsequently admitted to the hospital.
from Dementia Big http://ift.tt/1MHYRc2
via Stopping Dementia
Traumatic brain injury (TBI), a leading cause of death and disability, has become so common in recent times that it has been called a “silent epidemic.” And because older adults are more likely to suffer TBI, have worse outcomes, and are less likely to survive their injury than younger adults, older adults are considered a “silent population” within this epidemic.
from Dementia Big http://ift.tt/26eQuuY
via Stopping Dementia
The effects of the plaques on the brains of Alzheimer’s patients are devastating.
from Dementia Big http://ift.tt/23ZKOTz
via Stopping Dementia
Long before Alzheimer’s disease can be diagnosed clinically, increasing difficulties building cognitive maps of new surroundings may herald the eventual clinical onset of the disorder, finds new research from Washington University in St. Louis.
from Dementia Big http://ift.tt/26eEdH3
via Stopping Dementia
In a study published in the Journal of the American Geriatrics Society, researchers examined whether or not antipsychotic drugs, which are sometimes used to prevent or treat delirium, are effective.
from Dementia Big http://ift.tt/1qYQXkL
via Stopping Dementia
We studied the mortality risk of long term and new antipsychotic drug use in Alzheimer’s disease (AD) patients in Japan to determine improved treatment protocols.
from Dementia Big http://ift.tt/1Ss9a33
via Stopping Dementia
For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer’s disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.
from Dementia Big http://ift.tt/1SkPOuy via alcoholic dementia
A new study from the Indiana University Center for Aging Research and the Regenstrief Institute has found that almost half of all long-stay nursing home residents experience at least one transfer to an Emergency Department over the course of a year regardless of their cognitive status. While a high percentage of long-stay nursing home residents were sent to the ED, only about a third of these individuals were subsequently admitted to the hospital.
from Dementia Big http://ift.tt/1MHYRc2 via alcoholic dementia
The effects of the plaques on the brains of Alzheimer’s patients are devastating.
from Dementia Big http://ift.tt/23ZKOTz via alcoholic dementia
In a study published in the Journal of the American Geriatrics Society, researchers examined whether or not antipsychotic drugs, which are sometimes used to prevent or treat delirium, are effective.
from Dementia Big http://ift.tt/1qYQXkL via alcoholic dementia
Traumatic brain injury (TBI), a leading cause of death and disability, has become so common in recent times that it has been called a “silent epidemic.” And because older adults are more likely to suffer TBI, have worse outcomes, and are less likely to survive their injury than younger adults, older adults are considered a “silent population” within this epidemic.
from Dementia Big http://ift.tt/26eQuuY via alcoholic dementia
We studied the mortality risk of long term and new antipsychotic drug use in Alzheimer’s disease (AD) patients in Japan to determine improved treatment protocols.
from Dementia Big http://ift.tt/1Ss9a33 via alcoholic dementia
Long before Alzheimer’s disease can be diagnosed clinically, increasing difficulties building cognitive maps of new surroundings may herald the eventual clinical onset of the disorder, finds new research from Washington University in St. Louis.
from Dementia Big http://ift.tt/26eEdH3 via alcoholic dementia
Dementia Big
A new study from the Indiana University Center for Aging Research and the Regenstrief Institute has found that almost half of all long-stay nursing home residents experience at least one transfer to an Emergency Department over the course of a year regardless of their cognitive status. While a high percentage of long-stay nursing home residents were sent to the ED, only about a third of these individuals were subsequently admitted to the hospital.
Dementia Big
The UK has seen a 20% fall in the incidence of dementia over the past two decades, according to new research from England, led by the University of Cambridge, leading to an estimated 40,000 fewer cases of dementia than previously predicted. However, the study, published today in Nature Communications, suggests that the dramatic change has been observed mainly in men.
Dementia Big
Research co-led by the University of Glasgow has made a potential breakthrough in the treatment of Alzheimer’s disease.
The UK has seen a 20% fall in the incidence of dementia over the past two decades, according to new research from England, led by the University of Cambridge, leading to an estimated 40,000 fewer cases of dementia than previously predicted. However, the study, published today in Nature Communications, suggests that the dramatic change has been observed mainly in men.
from Dementia Big http://ift.tt/1Sqqqpp
via Stopping Dementia
A new study from the Indiana University Center for Aging Research and the Regenstrief Institute has found that almost half of all long-stay nursing home residents experience at least one transfer to an Emergency Department over the course of a year regardless of their cognitive status. While a high percentage of long-stay nursing home residents were sent to the ED, only about a third of these individuals were subsequently admitted to the hospital.
from Dementia Big http://ift.tt/22L5ewY
via Stopping Dementia
Research co-led by the University of Glasgow has made a potential breakthrough in the treatment of Alzheimer’s disease.
from Dementia Big http://ift.tt/1NyUtqD
via Stopping Dementia
The UK has seen a 20% fall in the incidence of dementia over the past two decades, according to new research from England, led by the University of Cambridge, leading to an estimated 40,000 fewer cases of dementia than previously predicted. However, the study, published today in Nature Communications, suggests that the dramatic change has been observed mainly in men.
from Dementia Big http://ift.tt/1Sqqqpp via alcoholic dementia
A new study from the Indiana University Center for Aging Research and the Regenstrief Institute has found that almost half of all long-stay nursing home residents experience at least one transfer to an Emergency Department over the course of a year regardless of their cognitive status. While a high percentage of long-stay nursing home residents were sent to the ED, only about a third of these individuals were subsequently admitted to the hospital.
from Dementia Big http://ift.tt/22L5ewY via alcoholic dementia
Research co-led by the University of Glasgow has made a potential breakthrough in the treatment of Alzheimer’s disease.
from Dementia Big http://ift.tt/1NyUtqD via alcoholic dementia
A Centre for Healthy Brain Ageing (CHeBA) paper published in Current Alzheimer Research presents the first detailed study of the relationship between plasma levels of two amyloid beta peptides (Aβ1-40 and Aβ1-42), brain volumetrics (measures studying the size of brain, which shrinks with Alzheimer’s disease) and cognitive performance in an investigation of the usefulness of plasma levels as a biomarker for Alzheimer’s disease (AD).
from Dementia Big http://ift.tt/1XFc3z0
via Stopping Dementia
Identifying factors associated with lower dementia care costs is essential. We examined whether two caregiver factors were associated with lower costs of informal care.
from Dementia Big http://ift.tt/1SWnpuG
via Stopping Dementia
As the relationship between delirium and long-term cognitive decline has not been well-explored, we evaluated this association in a prospective study.
from Dementia Big http://ift.tt/1SWnsGG
via Stopping Dementia
Georgetown University researchers are reporting the first case of Alzheimer’s disease diagnosed in an HIV-positive individual. The finding in a 71-year-old man triggers a realization about HIV survivors now reaching the age when Alzheimer’s risk begins to escalate.
from Dementia Big http://ift.tt/23TkGcV
via Stopping Dementia
We assessed the association of gamma glutamyltransferase (GGT) with risk of dementia.
from Dementia Big http://ift.tt/1SWnpuv
via Stopping Dementia
Transition to bathing or dressing disability is a milestone in the evolution of dementia. We examined the transition to disability in these specific activities and considered death to be a competitive event and age and sex to be prognostic factors.
from Dementia Big http://ift.tt/1VfmBqV
via Stopping Dementia
Dementia Big
As the relationship between delirium and long-term cognitive decline has not been well-explored, we evaluated this association in a prospective study.
Dementia Big
Georgetown University researchers are reporting the first case of Alzheimer’s disease diagnosed in an HIV-positive individual. The finding in a 71-year-old man triggers a realization about HIV survivors now reaching the age when Alzheimer’s risk begins to escalate.
Dementia Big
A Centre for Healthy Brain Ageing (CHeBA) paper published in Current Alzheimer Research presents the first detailed study of the relationship between plasma levels of two amyloid beta peptides (Aβ1-40 and Aβ1-42), brain volumetrics (measures studying the size of brain, which shrinks with Alzheimer’s disease) and cognitive performance in an investigation of the usefulness of plasma levels as a biomarker for Alzheimer’s disease (AD).
Dementia Big
We assessed the association of gamma glutamyltransferase (GGT) with risk of dementia.
Dementia Big
Identifying factors associated with lower dementia care costs is essential. We examined whether two caregiver factors were associated with lower costs of informal care.
Dementia Big
Transition to bathing or dressing disability is a milestone in the evolution of dementia. We examined the transition to disability in these specific activities and considered death to be a competitive event and age and sex to be prognostic factors.
A Centre for Healthy Brain Ageing (CHeBA) paper published in Current Alzheimer Research presents the first detailed study of the relationship between plasma levels of two amyloid beta peptides (Aβ1-40 and Aβ1-42), brain volumetrics (measures studying the size of brain, which shrinks with Alzheimer’s disease) and cognitive performance in an investigation of the usefulness of plasma levels as a biomarker for Alzheimer’s disease (AD).
from Dementia Big http://ift.tt/1XFc3z0 via alcoholic dementia
As the relationship between delirium and long-term cognitive decline has not been well-explored, we evaluated this association in a prospective study.
from Dementia Big http://ift.tt/1SWnsGG via alcoholic dementia
Identifying factors associated with lower dementia care costs is essential. We examined whether two caregiver factors were associated with lower costs of informal care.
from Dementia Big http://ift.tt/1SWnpuG via alcoholic dementia
Georgetown University researchers are reporting the first case of Alzheimer’s disease diagnosed in an HIV-positive individual. The finding in a 71-year-old man triggers a realization about HIV survivors now reaching the age when Alzheimer’s risk begins to escalate.
from Dementia Big http://ift.tt/23TkGcV via alcoholic dementia
We assessed the association of gamma glutamyltransferase (GGT) with risk of dementia.
from Dementia Big http://ift.tt/1SWnpuv via alcoholic dementia
Transition to bathing or dressing disability is a milestone in the evolution of dementia. We examined the transition to disability in these specific activities and considered death to be a competitive event and age and sex to be prognostic factors.
from Dementia Big http://ift.tt/1VfmBqV via alcoholic dementia
Compared to Caucasians, African Americans (AAs) have higher dementia prevalence, different genetic markers, and higher vascular risk factors. However, pathologic underpinnings are unknown.
from Dementia Big http://ift.tt/1Se0wmu via alcoholic dementia
Compared to Caucasians, African Americans (AAs) have higher dementia prevalence, different genetic markers, and higher vascular risk factors. However, pathologic underpinnings are unknown.
from Dementia Big http://ift.tt/1Se0wmu
via Stopping Dementia
Dementia Big
Compared to Caucasians, African Americans (AAs) have higher dementia prevalence, different genetic markers, and higher vascular risk factors. However, pathologic underpinnings are unknown.
Dementia Big
(HealthDay)—Self-management group rehabilitation is beneficial for persons with dementia (PwD) and their spouses, according to a study published online April 5 in the Journal of the American Geriatrics Society.
Dementia Big
The National Alzheimer’s Project Act (NAPA) was signed into law in 2011. Over the past five years milestones have been identified to meet the plan’s biomedical research goal. However, similar milestones have not been created for the goals on patient care and caregiver support.
Dementia Big
Alzheimer’s disease is caused by protein (amyloid) deposition in the brain. New research at the University of Bergen (UiB) and Haukeland University Hospital shows that the protein PITRM1, which is found in mitochondria, otherwise known as the powerhouses of the cell, may be involved in the development of the disease.
Dementia Big
In a new paper published by The Journal of Alzheimer’s Disease, Professor Melissa Schilling, a strategy and innovation expert at the NYU Stern School of Business, uncovers a surprising new connection between diabetes and Alzheimer’s disease: hyperinsulinemia, which is most often caused by prediabetes, early or undiagnosed diabetes, or obesity, is responsible for almost half of all cases of Alzheimer’s disease.
(HealthDay)—Self-management group rehabilitation is beneficial for persons with dementia (PwD) and their spouses, according to a study published online April 5 in the Journal of the American Geriatrics Society.
from Dementia Big http://ift.tt/23zjn6c via alcoholic dementia
The National Alzheimer’s Project Act (NAPA) was signed into law in 2011. Over the past five years milestones have been identified to meet the plan’s biomedical research goal. However, similar milestones have not been created for the goals on patient care and caregiver support.
from Dementia Big http://ift.tt/1oY7Z0P via alcoholic dementia
In a new paper published by The Journal of Alzheimer’s Disease, Professor Melissa Schilling, a strategy and innovation expert at the NYU Stern School of Business, uncovers a surprising new connection between diabetes and Alzheimer’s disease: hyperinsulinemia, which is most often caused by prediabetes, early or undiagnosed diabetes, or obesity, is responsible for almost half of all cases of Alzheimer’s disease.
from Dementia Big http://ift.tt/22ujJ8n via alcoholic dementia
Alzheimer’s disease is caused by protein (amyloid) deposition in the brain. New research at the University of Bergen (UiB) and Haukeland University Hospital shows that the protein PITRM1, which is found in mitochondria, otherwise known as the powerhouses of the cell, may be involved in the development of the disease.
from Dementia Big http://ift.tt/1S6I6UT via alcoholic dementia
(HealthDay)—Self-management group rehabilitation is beneficial for persons with dementia (PwD) and their spouses, according to a study published online April 5 in the Journal of the American Geriatrics Society.
from Dementia Big http://ift.tt/23zjn6c
via Stopping Dementia
In a new paper published by The Journal of Alzheimer’s Disease, Professor Melissa Schilling, a strategy and innovation expert at the NYU Stern School of Business, uncovers a surprising new connection between diabetes and Alzheimer’s disease: hyperinsulinemia, which is most often caused by prediabetes, early or undiagnosed diabetes, or obesity, is responsible for almost half of all cases of Alzheimer’s disease.
from Dementia Big http://ift.tt/22ujJ8n
via Stopping Dementia
The National Alzheimer’s Project Act (NAPA) was signed into law in 2011. Over the past five years milestones have been identified to meet the plan’s biomedical research goal. However, similar milestones have not been created for the goals on patient care and caregiver support.
from Dementia Big http://ift.tt/1oY7Z0P
via Stopping Dementia
Alzheimer’s disease is caused by protein (amyloid) deposition in the brain. New research at the University of Bergen (UiB) and Haukeland University Hospital shows that the protein PITRM1, which is found in mitochondria, otherwise known as the powerhouses of the cell, may be involved in the development of the disease.
from Dementia Big http://ift.tt/1S6I6UT
via Stopping Dementia
Accurate diagnosis of Parkinson’s disease, and the related disease “dementia with Lewy bodies,” can be difficult in the early stages of both conditions. While brain biopsies can be more accurate, the risk of complications has been considered too high. New research published in the Journal of Parkinson’s Disease indicates that a biopsy of the submandibular gland can help identify the same pathology that is seen in the brain, providing some of the increased accuracy of brain biopsy, but not the increased risk.
from Dementia Big http://ift.tt/1qmOzDH
via Stopping Dementia
In a new paper published by The Journal of Alzheimer’s Disease, Professor Melissa Schilling, a strategy and innovation expert at the NYU Stern School of Business, uncovers a surprising new connection between diabetes and Alzheimer’s disease: hyperinsulinemia, which is most often caused by prediabetes, early or undiagnosed diabetes, or obesity, is responsible for almost half of all cases of Alzheimer’s disease.
from Dementia Big http://ift.tt/22syGYx
via Stopping Dementia
The National Alzheimer’s Project Act (NAPA) was signed into law in 2011. Over the past five years milestones have been identified to meet the plan’s biomedical research goal. However, similar milestones have not been created for the goals on patient care and caregiver support.
from Dementia Big http://ift.tt/1WqtF3e
via Stopping Dementia
The National Alzheimer’s Project Act (NAPA) was signed into law in 2011. Over the past five years milestones have been identified to meet the plan’s biomedical research goal. However, similar milestones have not been created for the goals on patient care and caregiver support.
from Dementia Big http://ift.tt/1WqtF3e via alcoholic dementia
In a new paper published by The Journal of Alzheimer’s Disease, Professor Melissa Schilling, a strategy and innovation expert at the NYU Stern School of Business, uncovers a surprising new connection between diabetes and Alzheimer’s disease: hyperinsulinemia, which is most often caused by prediabetes, early or undiagnosed diabetes, or obesity, is responsible for almost half of all cases of Alzheimer’s disease.
from Dementia Big http://ift.tt/22syGYx via alcoholic dementia
Accurate diagnosis of Parkinson’s disease, and the related disease “dementia with Lewy bodies,” can be difficult in the early stages of both conditions. While brain biopsies can be more accurate, the risk of complications has been considered too high. New research published in the Journal of Parkinson’s Disease indicates that a biopsy of the submandibular gland can help identify the same pathology that is seen in the brain, providing some of the increased accuracy of brain biopsy, but not the increased risk.
from Dementia Big http://ift.tt/1qmOzDH via alcoholic dementia
Dementia Big
Accurate diagnosis of Parkinson’s disease, and the related disease “dementia with Lewy bodies,” can be difficult in the early stages of both conditions. While brain biopsies can be more accurate, the risk of complications has been considered too high. New research published in the Journal of Parkinson’s Disease indicates that a biopsy of the submandibular gland can help identify the same pathology that is seen in the brain, providing some of the increased accuracy of brain biopsy, but not the increased risk.
Dementia Big
The National Alzheimer’s Project Act (NAPA) was signed into law in 2011. Over the past five years milestones have been identified to meet the plan’s biomedical research goal. However, similar milestones have not been created for the goals on patient care and caregiver support.
Dementia Big
In a new paper published by The Journal of Alzheimer’s Disease, Professor Melissa Schilling, a strategy and innovation expert at the NYU Stern School of Business, uncovers a surprising new connection between diabetes and Alzheimer’s disease: hyperinsulinemia, which is most often caused by prediabetes, early or undiagnosed diabetes, or obesity, is responsible for almost half of all cases of Alzheimer’s disease.
Writing in the April 11 issue of The Journal of Clinical Investigation, researchers at University of California, San Diego School of Medicine say abnormalities in a protein that helps transport and sort materials inside cells are linked to axonal dysfunction and degeneration of neurons in Alzheimer’s disease (AD) and Down syndrome (DS).
from Dementia Big http://ift.tt/1S85Ytr
via Stopping Dementia
More than half of our brains are made up of glial cells, which wrap around nerve fibers and insulate them–similarly to how the plastic casing of an electric cable insulates the copper wire within–allowing electrical and chemical impulses to travel faster.
from Dementia Big http://ift.tt/1T14mSn
via Stopping Dementia
More than half of our brains are made up of glial cells, which wrap around nerve fibers and insulate them–similarly to how the plastic casing of an electric cable insulates the copper wire within–allowing electrical and chemical impulses to travel faster.
from Dementia Big http://ift.tt/1T14mSn via alcoholic dementia
Writing in the April 11 issue of The Journal of Clinical Investigation, researchers at University of California, San Diego School of Medicine say abnormalities in a protein that helps transport and sort materials inside cells are linked to axonal dysfunction and degeneration of neurons in Alzheimer’s disease (AD) and Down syndrome (DS).
from Dementia Big http://ift.tt/1S85Ytr via alcoholic dementia
Dementia Big
Writing in the April 11 issue of The Journal of Clinical Investigation, researchers at University of California, San Diego School of Medicine say abnormalities in a protein that helps transport and sort materials inside cells are linked to axonal dysfunction and degeneration of neurons in Alzheimer’s disease (AD) and Down syndrome (DS).
Dementia Big
More than half of our brains are made up of glial cells, which wrap around nerve fibers and insulate them–similarly to how the plastic casing of an electric cable insulates the copper wire within–allowing electrical and chemical impulses to travel faster.
Writing in the April 11 issue of the Journal of Clinical Investigation, researchers at University of California, San Diego School of Medicine say abnormalities in a protein that helps transport and sort materials inside cells are linked to axonal dysfunction and degeneration of neurons in Alzheimer’s disease (AD) and Down syndrome (DS).
from Dementia Big http://ift.tt/1VixGHl via alcoholic dementia
(HealthDay)—Colonic diverticular disease appears to be associated with increased risk of dementia in a population from Taiwan, according to a study published online March 31 in the Journal of Gastroenterology and Hepatology.
from Dementia Big http://ift.tt/1VNAtY7 via alcoholic dementia
Identifying accurate biomarkers of cognitive decline is essential for advancing early diagnosis and prevention therapies in Alzheimer’s disease. The Alzheimer’s disease DREAM Challenge was designed as a computational crowdsourced project to benchmark the current state-of-the-art in predicting cognitive outcomes in Alzheimer’s disease based on high dimensional, publicly available genetic and structural imaging data. This meta-analysis failed to identify a meaningful predictor developed from either data modality, suggesting that alternate approaches should be considered for to prediction of cognitive performance.
from Dementia Big http://ift.tt/1YqB5BW via alcoholic dementia
How the human brain processes the words we hear and constructs complex concepts is still somewhat of a mystery to the neuroscience community. Transcranial direct current stimulation (tDCS) can alter our language processing, allowing for faster comprehension of meaningful word combinations, according to new research from the department of Neurology the Perelman School of Medicine at the University of Pennsylvania. The work is published in the Journal of Neuroscience.
from Dementia Big http://ift.tt/23xnLPP via alcoholic dementia
(HealthDay)—Colonic diverticular disease appears to be associated with increased risk of dementia in a population from Taiwan, according to a study published online March 31 in the Journal of Gastroenterology and Hepatology.
from Dementia Big http://ift.tt/1VNAtY7
via Stopping Dementia
Writing in the April 11 issue of the Journal of Clinical Investigation, researchers at University of California, San Diego School of Medicine say abnormalities in a protein that helps transport and sort materials inside cells are linked to axonal dysfunction and degeneration of neurons in Alzheimer’s disease (AD) and Down syndrome (DS).
from Dementia Big http://ift.tt/1VixGHl
via Stopping Dementia
How the human brain processes the words we hear and constructs complex concepts is still somewhat of a mystery to the neuroscience community. Transcranial direct current stimulation (tDCS) can alter our language processing, allowing for faster comprehension of meaningful word combinations, according to new research from the department of Neurology the Perelman School of Medicine at the University of Pennsylvania. The work is published in the Journal of Neuroscience.
from Dementia Big http://ift.tt/23xnLPP
via Stopping Dementia
Identifying accurate biomarkers of cognitive decline is essential for advancing early diagnosis and prevention therapies in Alzheimer’s disease. The Alzheimer’s disease DREAM Challenge was designed as a computational crowdsourced project to benchmark the current state-of-the-art in predicting cognitive outcomes in Alzheimer’s disease based on high dimensional, publicly available genetic and structural imaging data. This meta-analysis failed to identify a meaningful predictor developed from either data modality, suggesting that alternate approaches should be considered for to prediction of cognitive performance.
from Dementia Big http://ift.tt/1YqB5BW
via Stopping Dementia
Dementia Big
How the human brain processes the words we hear and constructs complex concepts is still somewhat of a mystery to the neuroscience community. Transcranial direct current stimulation (tDCS) can alter our language processing, allowing for faster comprehension of meaningful word combinations, according to new research from the department of Neurology the Perelman School of Medicine at the University of Pennsylvania. The work is published in the Journal of Neuroscience.
Dementia Big
(HealthDay)—Colonic diverticular disease appears to be associated with increased risk of dementia in a population from Taiwan, according to a study published online March 31 in the Journal of Gastroenterology and Hepatology.
Dementia Big
Writing in the April 11 issue of the Journal of Clinical Investigation, researchers at University of California, San Diego School of Medicine say abnormalities in a protein that helps transport and sort materials inside cells are linked to axonal dysfunction and degeneration of neurons in Alzheimer’s disease (AD) and Down syndrome (DS).
Dementia Big
Identifying accurate biomarkers of cognitive decline is essential for advancing early diagnosis and prevention therapies in Alzheimer’s disease. The Alzheimer’s disease DREAM Challenge was designed as a computational crowdsourced project to benchmark the current state-of-the-art in predicting cognitive outcomes in Alzheimer’s disease based on high dimensional, publicly available genetic and structural imaging data. This meta-analysis failed to identify a meaningful predictor developed from either data modality, suggesting that alternate approaches should be considered for to prediction of cognitive performance.
Alzheimer’s not only steals people’s memories but also their ability to recognize faces, which widens the gulf between people with this disease and their loved ones. A recent study has demonstrated that, beyond causing memory problems, Alzheimer’s disease also impairs visual face perception. This finding may help families better understand their loved one’s inevitable difficulties and lead to new avenues to postpone this painful aspect of the disease. Research in this area by the team of Dr. Sven Joubert, PhD, a researcher at the Centre de recherche de l'Institut universitaire de gériatrie de Montréal and a professor with the Department of Psychology at Université de Montréal, will be published tomorrow in the Journal of Alzheimer’s Disease.
from Dementia Big http://ift.tt/1S0gKj8 via alcoholic dementia
Alzheimer’s not only steals people’s memories but also their ability to recognize faces, which widens the gulf between people with this disease and their loved ones. A recent study has demonstrated that, beyond causing memory problems, Alzheimer’s disease also impairs visual face perception. This finding may help families better understand their loved one’s inevitable difficulties and lead to new avenues to postpone this painful aspect of the disease. Research in this area by the team of Dr. Sven Joubert, PhD, a researcher at the Centre de recherche de l’Institut universitaire de gériatrie de Montréal and a professor with the Department of Psychology at Université de Montréal, will be published tomorrow in the Journal of Alzheimer’s Disease.
from Dementia Big http://ift.tt/1S0gKj8
via Stopping Dementia
Dementia Big
Alzheimer’s not only steals people’s memories but also their ability to recognize faces, which widens the gulf between people with this disease and their loved ones. A recent study has demonstrated that, beyond causing memory problems, Alzheimer’s disease also impairs visual face perception. This finding may help families better understand their loved one’s inevitable difficulties and lead to new avenues to postpone this painful aspect of the disease. Research in this area by the team of Dr. Sven Joubert, PhD, a researcher at the Centre de recherche de l'Institut universitaire de gériatrie de Montréal and a professor with the Department of Psychology at Université de Montréal, will be published tomorrow in the Journal of Alzheimer’s Disease.
(HealthDay)—Autosomal dominant Alzheimer’s disease is associated with increased white matter hyperintensities (WMH) on magnetic resonance imaging well before expected symptom onset, according to a study published online March 26 in the Annals of Neurology.
from Dementia Big http://ift.tt/1qARJEP
via Stopping Dementia
Dementia Big
(HealthDay)—Autosomal dominant Alzheimer’s disease is associated with increased white matter hyperintensities (WMH) on magnetic resonance imaging well before expected symptom onset, according to a study published online March 26 in the Annals of Neurology.
